PRODUCT LITERATURE

Effect of inosiplex (Isoprinosine®) on induced human influenza A infection

---

A double blind prospective controlled study to evaluate the effect of inosiplex in induced human influenza A infection was carried out. Inosiplex was administered in therapeutic (starting 48 h following challenge) or prophylactic-therapeutic
(starting 48 h prior to challenge) manner in a dose of 4 g per day. Although the number of volunteers with clinical illness in the two treatment groups was not significantly different as compared to placebo, the volunteers had significantly
fewer and less severe symptoms

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Moprin

Specific Detail Info

Journal of Antimicrobial Chemotherapy (1981)7, 389-397

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment